27990 Federal Register / Vol. 63, No. 98 /Thursday, May 21, 1998 / Notices

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Health Care Financing Administration

[Document Identifier: HCFA–R–237]

Agency Information Collection

Activities: Proposed Collection;

Comment Request

In compliance with the requirement

of section 3506(c)(2)(A) of the

Paperwork Reduction Act of 1995, the

Health Care Financing Administration

(HCFA), Department of Health and

Human Services, is publishing the

following summary of proposed

collections for public comment.

Interested persons are invited to send

comments regarding the burden

estimate or any other aspect of this

collection of information, including any

of the following subjects: (1) The

necessity and utility of the proposed

information collection for the proper

performance of the agency’s functions;

(2) the accuracy of the estimated

burden; (3) ways to enhance the quality,

utility, and clarity of the information to

be collected; and (4) the use of

automated collection techniques or

other forms of information technology to

minimize the information collection

burden.

Type of Information Collection

Request: New Collection; Title of

Information Collection: Multi-State

Evaluation of Dual Eligibles

Demonstration; Form No.: HCFA–R–237

OMB #0938–NEW; Use: This survey

provides information needed to evaluate

dual eligible demonstrations on issues

of satisfaction and gather health and

functional status to be used in other

analyses. Dual eligible demonstrations

provide HCFA the opportunity to

determine whether changes in payment

and reimbursement and alternative

ways to provide health services results

in better coordination, increased

satisfaction, and improved outcomes of

those eligible for both Medicare and

Medicaid. Respondents to the survey

include demonstration enrollees both

living in the community and in

institutions, their families, disenrollees

and corresponding comparison groups.

Frequency: One time submission;

Affected Public: Individuals or

Households; Number of Respondents:

2,900; Total Annual Responses: 2,900;

Total Annual Hours: 2,106.

To obtain copies of the supporting

statement for the proposed paperwork

collections referenced above, E-mail

your request, including your address

and phone number, to

Paperwork@hcfa.gov, or call the Reports

Clearance Office on (410) 786–1326.

Written comments and

recommendations for the proposed

information collections must be mailed

within 60 days of this notice directly to

the HCFA Paperwork Clearance Officer

designated at the following address:

HCFA, Office of Information Services,

Information Technology Investment

Management Group, Division of HCFA

Enterprise Standards, Attention: John

Rudolph, Room C2–26–17, 7500

Security Boulevard, Baltimore,

Maryland 21244–1850.

Dated: May 11, 1998.

John P. Burke III,

HCFA Reports Clearance Officer, Division of

HCFA Enterprise Standards, Health Care

Financing Administration.

[FR Doc. 98–13575 Filed 5–20–98; 8:45 am]

BILLING CODE 4120–03–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Caner Institute; Meeting

Pursuant to Section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following meeting

of the National Cancer Institute

Frederick Cancer Research and

Development Center Advisory

Committee.

The open portion of the meeting will

be limited to space available.

Individuals who plan to attend and

need special assistance, such as sign

language interpretation or other

reasonable accommodations, should

notify the contact person in advance of

the meeting.

Committee Name: Frederick Cancer

Research and Development Center Advisory

Committee.

Date: June 11–12, 1998.

Place: Frederick Cancer Research and

Development Center, Building 549, Executive

Board Room, Frederick, Maryland 21702–

1201.

Open: 8:30 a.m.—10:00 a.m.

Agenda: Discussion of administrative

matters such as future meetings, budget and

information items related to the operation of

the NCI Frederick Cancer Research and

Development Center.

Closed: June 11–10:00 a.m. to Recess, June

12–10:00 a.m. to Adjournment.

Agenda/Purpose: Presentations and

discussions of previous site visit report and

response for the Molecular Basis of

Carcinogenesis Laboratory held December

11–12, 1997. There will be a site review of

the Chemistry of Carcinogenesis Laboratory

and a review of two Principal Investigators in

the Molecular Virology and Carcinogenesis

Laboratory both with ABL–Basic Research

Program contract.

Contact Person: David J. Goldstein, Ph.D.,

Executive Secretary, Frederick Cancer

Research and Development Center, P.O. Box

B, Frederick, MD 21702–1201, Telephone:

301–846–1108.

The meeting will be closed in accordance

with the provisions set forth in secs.

552b(c)(4) and 552(C)(6), Title 5, U.S.C. The

report and the discussions could reveal

confidential trade secrets or commercial

property such as patentable material and

personal information concerning individuals

associated with the programs, disclosure of

which would constitute a clearly

unwarranted invasion of personal privacy.

(Catalog of Federal Domestic Assistance

Program Numbers: 93.393, Cancer Cause and

Prevention Research; 93.394, Cancer

Detection and Diagnosis Research; 93.395,

Cancer Treatment Research; 93.396, Cancer

Biology Research; 93.397, Cancer Centers

Support; 93.398, Cancer Research Manpower;

93.399, Cancer Control)

Dated: May 13, 1998.

Anna Snouffer,

Acting NIH Committee Management Officer.

[FR Doc. 98–13535 Filed 5–20–98; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Cancer Institute; Notice of

Meeting

Pursuant to Section 10(a) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of a meeting of the

President’s Cancer Panel.

This meeting will be open to the

public as indicated below, with

attendance by the public limited to

space available. Individuals who plan to

attend and need special assistance, such

as sign language interpretation or other

reasonable accommodations, should

notify Linda Quick-Cameron,

Committee Management Officer,

National Cancer Institute, Executive

Plaza North, Room 609, 6130 Executive

Blvd., MSC 7410, Bethesda, MD 20892–

7410 (301/496–5708). A summary of the

meeting and the roster of committee

members will be provided upon request.

Other information pertaining to the

meeting may be obtained from the

contract person indicated below.

Committee Name: President’s Cancer

Panel.

Date: June 2, 1998.

Place: Yale University, Hope 110 Lecture

Hall, 315 Cesar Street, New Haven, CT.

Open: 9:30 a.m. to Adjournment.

Agenda: Quality of Cancer Care/Quality of

Life, Defining Quality of Life and

Survivorship.

Contract Person: Maureen O. Wilson, Ph.

D., Executive Secretary, National Cancer